Oncology Brothers ✓

@OncBrothers · joined 09 Aug 2021

Practice changing discussions by community oncologists-Rohit Gosain @RoswellPark & Rahul Gosain @WilmotCancer. OwnViews/NoMedAdvice.COI https://t.co/cJOjp0RvQE

21 892Followers

495Following

6 980Posts total

24.6KViews on collected posts

Postingan terbaru

Oncology Brothers ✓@OncBrothers9 Sep

This is the algorithm we have used during our discussion with @NicoGagelmann on Myelofibrosis! ✅ JAK Inhibitors (regardless of JAK mutation) ✅ Seqeuncing ✅ Supportive care #OncTwitter #MedTwitter #HemeTwitter @OncUpdates #MPNsm https://t.co/tuIilUHbMp

1K views · 12 likes · 5 reposts · 0 replies Open on X →

Oncology Brothers ✓@OncBrothers7 Sep

@OncBrothers @US_FDA @OncoAlert @drsarahsam @stolaney1 @PTarantinoMD @dr_yakupergun @BijoyTelivala @RenoHemonc @Dr_RShatsky @hoperugo @jhaveri_komal @SuyogCancer Not a fan of accelerated approvals) **the lack of evidence that switching at ESR1mutation detection is superior to sw

636 views · 3 likes · 0 reposts · 0 replies Open on X →

Oncology Brothers ✓@OncBrothers7 Sep

To close MPN discussion, here we have Treatment Algorithm 🗣️ for Myelofibrosis w/ @NicoGagelmann ✅ WorkUp ✅ Supportive Care ✅ Rx options/sequencing Full 🗣️: - https://t.co/Q0xeN0yukm - “Oncology Brothers” podcast #HemeTwitter @OncUpdates #MPNsm https://t.co/EqDrhrF6uV

1:59

2.3K views · 16 likes · 5 reposts · 0 replies Open on X →

Oncology Brothers ✓@OncBrothers5 Sep

In this ToxCheck discussion, we touched on dosing, AEs, and clinical pearls in managing these cytoreductive therapies (and Rusfertide) #MPNsm ✅ Hydroxyurea ✅ RopegIFN ✅ Ruxolitinib ✅ Rusfertide Here our the tables we’ve used 👇👇 #HemeTwitter @OncoAlert @doctorpemm https://t

3.3K views · 20 likes · 8 reposts · 2 replies Open on X →

Oncology Brothers ✓@OncBrothers4 Sep

@OncBrothers @US_FDA @OncoAlert @drsarahsam @stolaney1 @PTarantinoMD @dr_yakupergun @BijoyTelivala @RenoHemonc @Dr_RShatsky @hoperugo @jhaveri_komal @SuyogCancer This is so true 145 views · 0 likes · 0 reposts · 0 replies Open on X →

Oncology Brothers ✓@OncBrothers4 Sep

@OncBrothers @US_FDA @OncoAlert @drsarahsam @stolaney1 @PTarantinoMD @dr_yakupergun @BijoyTelivala @RenoHemonc @Dr_RShatsky @hoperugo @jhaveri_komal @SuyogCancer Wife starts capivasertib plus fulvestrant on the 14th as her MBC is now in her liver. Please, please, please can we ju 177 views · 2 likes · 0 reposts · 0 replies Open on X →

Oncology Brothers ✓@OncBrothers4 Sep

After #ASCO25 Plenary, Camizestrant is now @US_FDA ✅ based off #SERENA6: PhIII, Camizestrant + CDK4/6i vs AI + CDK4/6i for emerging ESR1m before progression. - mPFS2: 25.7mos vs. 19.1mos (HR: 0.63) - mPFS: 16.8mos vs. 9.2mos (HR: 0.45) #OncTwitter #bcsm #MedX @OncoAlert https:

12.6K views · 32 likes · 16 reposts · 3 replies Open on X →

Oncology Brothers ✓@OncBrothers4 Sep

ToxCheck: AEs that we see (+ clinical pearls) from our cytoreductive options in PV & ET w/ @doctorpemm & #DrBrandiReeves ✅ Hydroxyurea ✅ RopegIFN ✅ Ruxolitinib *and Rusfertide* Full 🗣️ ⭐️ https://t.co/vegUNhHcRI ⭐️ “Oncology Brothers” podcast #HemeTwitter #MPNsm https://t.co

1:40

4.3K views · 12 likes · 4 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

8 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. tampil luas, tetapi sedikit penonton yang merespons.

Median tayangan1 672akun ini924median untuk 10K–100K

Jangkauan, %7.64%akun ini3.62%median untuk 10K–100K

Interaksi, %0.77%akun ini1.52%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	1 672	924	1.81×
Jangkauan (tayangan ÷ pengikut)	7.64%	3.62%	2.11×
Tingkat interaksi	0.77%	1.52%	0.50×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

4.3K4 Sep

12.6K

177

145

3.3K5 Sep

2.3K7 Sep

636

1K9 Sep

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.39%4 Sep

0.43%

1.13%

0.00%

0.91%5 Sep

0.95%7 Sep

0.63%

1.67%9 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes59.9%97 in total

Reposts23.5%38 in total

Replies3.1%5 in total

Quotes3.7%6 in total

Bookmarks9.9%16 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Postingan terbaru

Dibandingkan akun berukuran sama

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Akun serupa